{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T19:45:14Z","timestamp":1784231114455,"version":"3.55.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,4]],"date-time":"2024-03-04T00:00:00Z","timestamp":1709510400000},"content-version":"vor","delay-in-days":3,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100020582","name":"National Institute of Pharmaceutical Education and Research, Raebareli","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020582","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.heliyon.2024.e27602","type":"journal-article","created":{"date-parts":[[2024,3,11]],"date-time":"2024-03-11T05:57:50Z","timestamp":1710136670000},"page":"e27602","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Repurposing of Food and Drug Admnistration (FDA) approved library to identify a potential inhibitor of trypanothione synthetase for developing an antileishmanial agent"],"prefix":"10.1016","volume":"10","author":[{"given":"Divya","family":"Vemula","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shreelekha","family":"Mohanty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasundhra","family":"Bhandari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.heliyon.2024.e27602_bib1","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.3390\/pharmaceutics14081590","article-title":"Metabolic pathways of Leishmania parasite: source of pertinent drug targets and potent drug candidates","volume":"14","author":"Jain","year":"2022","journal-title":"Pharmaceutics"},{"issue":"6","key":"10.1016\/j.heliyon.2024.e27602_bib2","article-title":"Visceral leishmaniasis (Kala-Azar): a triumph against a trickster disease","volume":"14","author":"Pasha","year":"2022","journal-title":"Cureus"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e27602_bib4","article-title":"Vaccination in leishmaniasis: a review article","volume":"26","author":"Abdellahi","year":"2022","journal-title":"IBJ"},{"key":"10.1016\/j.heliyon.2024.e27602_bib5","article-title":"Treatment of leishmaniasis","volume":"67","author":"Sivayogana","year":"2022","journal-title":"Leishmaniasis: General Aspects of a Stigmatized Disease"},{"key":"10.1016\/j.heliyon.2024.e27602_bib6","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.actatropica.2018.02.010","article-title":"Recent progress in drug targets and inhibitors towards combating leishmaniasis","volume":"181","author":"Vijayakumar","year":"2018","journal-title":"Acta Trop."},{"issue":"15","key":"10.1016\/j.heliyon.2024.e27602_bib7","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.2174\/1381612826666201211115329","article-title":"Trypanothione metabolism as drug target for trypanosomatids","volume":"27","author":"Pi\u00f1eyro","year":"2021","journal-title":"Curr. Pharmaceut. Des."},{"key":"10.1016\/j.heliyon.2024.e27602_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12639-010-0006-3","article-title":"Drug targets in Leishmania","volume":"34","author":"Chawla","year":"2010","journal-title":"J. Parasit. Dis."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e27602_bib9","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1080\/14756366.2022.2045590","article-title":"Drug-like molecules with anti-trypanothione synthetase activity identified by high throughput screening","volume":"37","author":"Ben\u00edtez","year":"2022","journal-title":"J. Enzym. Inhib. Med. Chem."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e27602_bib10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0097600","article-title":"Stage-dependent expression and up-regulation of trypanothione synthetase in amphotericin B resistant Leishmania donovani","volume":"9","author":"Equbal","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.heliyon.2024.e27602_bib11","unstructured":"Toward new antileishmanial compounds: molecular targets for leishmaniasis treatment. In Leishmaniasis-General Aspects of a Stigmatized Disease. IntechOpen.."},{"key":"10.1016\/j.heliyon.2024.e27602_bib12","article-title":"In silico prediction, characterization, molecular docking, and dynamic studies on fungal SDRs as novel targets for searching potential fungicides against Fusarium wilt in tomato","volume":"1038","author":"Aamir","year":"2018","journal-title":"Front. Pharmacol."},{"issue":"23","key":"10.1016\/j.heliyon.2024.e27602_bib13","doi-asserted-by":"crossref","first-page":"10780","DOI":"10.1007\/s10853-022-07195-8","article-title":"Drug repurposing for SARS-CoV-2: a high-throughput molecular docking, molecular dynamics, machine learning, and DFT study","volume":"57","author":"Kashyap","year":"2022","journal-title":"J. Math. Sci."},{"key":"10.1016\/j.heliyon.2024.e27602_bib14","first-page":"1","article-title":"In-silico investigation of E8 surface protein of the monkeypox virus to identify potential therapeutic agents","author":"Podduturi","year":"2023","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"suppl_2","key":"10.1016\/j.heliyon.2024.e27602_bib15","article-title":"NCBI BLAST: a better web interface","volume":"36","author":"Johnson","year":"2008","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e27602_bib16","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/pro.3290","article-title":"Clustal Omega for making accurate alignments of many protein sequences","volume":"27","author":"Sievers","year":"2018","journal-title":"Protein Sci."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e27602_bib17","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.sjbs.2020.10.023","article-title":"In-silico protein-ligand docking studies against the estrogen protein of breast cancer using pharmacophore based virtual screening approaches","volume":"28","author":"Sahayarayan","year":"2021","journal-title":"Saudi J. Biol. Sci."},{"key":"10.1016\/j.heliyon.2024.e27602_bib18","series-title":"Schr\u00f6dinger Release 2015\u20133: Ligprep","author":"Schr\u00f6dinger","year":"2015"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e27602_bib19","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s11030-021-10276-6","article-title":"In silico screening of neurokinin receptor antagonists as a therapeutic strategy for neuroinflammation in Alzheimer's disease","volume":"26","author":"Satarker","year":"2022","journal-title":"Mol. Divers."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e27602_bib20","first-page":"1402","article-title":"Virtual screening and molecular dynamics simulation study of plant-derived compounds to identify potential inhibitors of main protease from SARS-CoV-2. Brief","volume":"22","author":"Mahmud","year":"2021","journal-title":"Bioinformatics"},{"issue":"8","key":"10.1016\/j.heliyon.2024.e27602_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0268269","article-title":"Molecular docking, simulation and binding free energy analysis of small molecules as Pf HT1 inhibitors","volume":"17","author":"Owoloye","year":"2022","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e27602_bib22","first-page":"1402","article-title":"Virtual screening and molecular dynamics simulation study of plant-derived compounds to identify potential inhibitors of main protease from SARS-CoV-2. Brief","volume":"22","author":"Mahmud","year":"2021","journal-title":"Bioinformatics"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e27602_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep06948","article-title":"Identification of novel tyrosine kinase inhibitors for drug resistant T315I mutant BCR-ABL: a virtual screening and molecular dynamics simulations study","volume":"4","author":"Banavath","year":"2014","journal-title":"Sci. Rep."},{"key":"10.1016\/j.heliyon.2024.e27602_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2023.1087676","article-title":"Homology modeling, virtual screening, molecular docking, and dynamics studies for discovering Staphylococcus epidermidis FtsZ inhibitors","volume":"10","author":"Vemula","year":"2023","journal-title":"Front. Mol. Biosci."},{"issue":"W1","key":"10.1016\/j.heliyon.2024.e27602_bib25","doi-asserted-by":"crossref","first-page":"W257","DOI":"10.1093\/nar\/gky318","article-title":"ProTox-II: a webserver for the prediction of toxicity of chemicals","volume":"46","author":"Banerjee","year":"2018","journal-title":"Nucleic Acids Res."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024036338?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024036338?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T20:34:04Z","timestamp":1782246844000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844024036338"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":24,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S2405844024036338"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e27602","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Repurposing of Food and Drug Admnistration (FDA) approved library to identify a potential inhibitor of trypanothione synthetase for developing an antileishmanial agent","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e27602","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e27602"}}